Heerak Kang, MD
Pain Medicine · Las Vegas, NVNPI 1871026518
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $6,742 of the $10,763 with a category attached, or 62.6%. 8 manufacturers reported payments, led by Abbott at 36.5% of the total.
Across 69 payments — averaging $155.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Boston Scientific$3K
- Saluda Medical Americas, Inc.$2K
- Nevro Corp.$720
- SPR Therapeutics, Inc$519
- Medtronic$417
- plus $53 from 2 others
What the payments were for
- Speaking & faculty fees$7177%
- Travel & lodging$6,74263%
- Food & beverage$3,30431%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 25 | $3,931 |
| Boston Scientific | 19 | $2,894 |
| Saluda Medical Americas, Inc. | 7 | $2,230 |
| Nevro Corp. | 2 | $720 |
| SPR Therapeutics, Inc | 7 | $519 |
| Medtronic | 7 | $417 |
| Si-bone, Inc. | 1 | $30 |
| Curonix LLC | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$3,570
- Evoke$2,128
- GENERAL - THERAPIES$1,167
- Omnia$717
- WAVEWRITER ALPHA$390
- SPECTRA WAVEWRITER$371
- WaveWriter Alpha Prime 16$273
- SPRINT PNS System$236
- RESTORE$219
- Intracept$168
How this compares
$10,763 in reported general payments places this provider in the 80th percentile of 101 pain medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 277 | $3,878 |
| Celecoxib | 31 | $1,728 |
| Pregabalin | 52 | $901 |
| Duloxetine Hcl | 83 | $822 |
| Baclofen | 24 | $411 |
| Cyclobenzaprine Hcl | 56 | $382 |
| Tizanidine Hcl | 21 | $128 |
| Meloxicam | 56 | $113 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $112 |
| Amitriptyline Hcl | 26 | $108 |
| Tramadol Hcl | 12 | $75 |
| Methylprednisolone | 11 | $67 |
| Oxycodone Hcl | 13 | $43 |
| Diazepam | 18 | $10 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Las Vegas
- Kunal ParikhLas Vegas$26K
- Nader HelmiLas Vegas$25K
- Sungkook ParkLas Vegas$20K
- Pouya MohajerLas Vegas$17K
- David AlvaradoLas Vegas$15K
- Okwuchukwu ObiLas Vegas$15K
- Christopher FisherLas Vegas$13K
- Andrew KimLas Vegas$11K
- Neville CampbellLas Vegas$11K
- Ruben AlexanderLas Vegas$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.